N 4 (189) 2024. P. 34–39

CLINICAL AND PATHOPHYSIOLOGICAL ASPECTS OF SPLENECTOMY AND SELECTIVE SPLENIC ARTERY LIGATION IN PATIENTS WITH DECOMPENSATED PORTAL HYPERTENSION

M. I. Tutchenko, D. V. Rudyk, S. L. Chub, M. S. Besedinskyi, I. V. Klusko, O. A. Sirenko

Bogomolets National Medical University, Kyiv, Ukraine
Kyiv Regional Clinical Hospital, Kyiv, Ukraine
Vyshgorod Central District Holspital, Vyshgorod, Ukraine

DOI 10.32782/2226-2008-2024-4-6

The research aims to demonstrate the difference in approaches to correcting hypersplenism in portal hypertension of various etiology.

Materials and methods. The approach of splenectomy (SE) and splenic artery ligation (SAL) without removal of the spleen during portoazygos disconnection in patients with upper variceal bleeding was compared. Differences in hematological changes and portal hemodynamics in the postoperative period were evinced. Participants: patients (n=37) with decompensated portal hypertension complicated by variceal bleeding, who underwent porto-azygos dissection and splenectomy formed group 1 (n=20), those who underwent porto-azygos dissection and splenic artery ligation formed group 2 (n=17). The comparative characteristics of surgical interventions in the two groups were performed.

Results. Diameter of the portal vein, blood flow and congestion index were correlated with spleen size and type of surgical intervention (p < 0.005). The increase in thrombotic activity after splenectomy was characterized by an increase in the number of platelets and changes in blood coagulation. Complications in the form of thrombosis of the portal and superior mesenteric veins were observed in patients after splenectomy with concomitant Covid-19 infection. In the patients of the second group, thromboembolic complications were not observed, instead, there were purulent-septic complications in the form of splenic infarction, subdiaphragmatic and intrapleural accumulation of pathological contents.

Conclusions. In the studied cohort of patients, the performance of splenectomy indicates a clinically significant improvement in portal hemodynamics. Decrease of intrahepatic blood flow due to reduction of splenic blood flow leads to improvement of liver function. Any type of reduction in splenic blood flow leads to an increased risk of thrombosis in the portal vein system.

Key words: portal hypertension, variceal bleeding, splenectomy, splenic artery ligation.

REFERENCES

  1. Leonardi F, Maria ND, Villa E. Anticoagulation in cirrhosis: a new paradigm? Clinical and Molecular Hepatology. 2017; 23(1): 13–21. https://doi.org/10.3350/cmh.2016.0110.
  2. O’Shea RS, Davitkov P, Ko CW, et al. AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis. 2021; 161(5): 1615–1627. https://doi.org/10.1053/j.gastro.2021.08.015.
  3. Primignani M. Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis. World Journal of Hepatology. 2015; 7(29): 2906. https://doi.org/10.4254/wjh.v7.i29.2906.
  4. Zhang X, Wang Y, Yu M, Huang J, Deng D, Xue H. Effective Prevention for Portal Venous System Thrombosis After Splenectomy: A Meta-Analysis. Journal of Laparoendoscopic & Advanced Surgical Techniques. 2017; 27(3): 247–252. https://doi.org/10.1089/lap.2016.0511.
  5. Li M.-X, Zhang X-F, Liu Z-W, Lv Yi. Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis. Hepatobiliary & Pancreatic Diseases International. 2013; 12(5): 512–519. https://doi.org/10.1016/s1499-3872(13)60081-8.
  6. Wang J-l, Li J, Wang W-q et al. Portal vein velocity predicts portal vein system thrombosis after splenectomy with esophagogastric devascularization Surgical Endoscopy. 2023; 38: 648–658. https://doi.org/10.1007/s00464-023-10566-0.
  7. Chawla YK, Bodh V. Portal Vein Thrombosis. Journal of Clinical and Experimental Hepatology. 2015; 5(1): 22–40. https://doi.org/10.1016/j.jceh.2014.12.008.
  8. Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md.). 2021; 73(1): 366–413. https://doi.org/10.1002/hep.31646.
  9. Jiang G-q, Bai D-s, Chen P, Qian J-j, Jin S-j, Wang X-h. Risk Factors for Portal Vein System Thrombosis After Laparoscopic Splenectomy in Cirrhotic Patients with Hypersplenism. Journal of Laparoendoscopic & Advanced Surgical Techniques. 2016; 26(6): 419–423. https://doi.org/10.1089/lap.2015.0481.
  10. Ahuja C, Farsad K, Chadha M. An Overview of Splenic Embolization. American Journal of Roentgenology. 2015; 205(4): 720–725. https://doi.org/10.2214/ajr.15.14637.
  11. Bai D-S, Qian J-J, Chen P. et al. Laparoscopic azygoportal disconnection with and without splenectomy for portal hypertension. International Journal of Surgery. 2016; 34: 116–121. https://doi.org/10.1016/j.ijsu.2016.08.519.
  12. Zhu W, Wang X, Lv Y et al. Comparison of long-term outcomes of splenectomy with periesophagogastric devascularization and transjugular intrahepatic portosystemic shunt in treating cirrhotic portal hypertension patients with recurrent variceal bleeding. Langenbeck’s Archives of Surgery. 2023; 408: 215. https://doi.org/10.1007/s00423-023-02933-1.
  13. Kurokawa T, Ohkohchi N. Platelets in liver disease, cancer and regeneration. World Journal of Gastroenterology. 2017; 23(18): 3228. https://doi.org/10.3748/wjg.v23.i18.3228.
  14. Zhang H, Zhang S, Zhang J, et al. Improvement of human platelet aggregation post-splenectomy with paraesophagogastric devascularization in chronic hepatitis B patients with cirrhotic hypersplenism. Platelets. 2020; 31(8): 1019–1027. https://doi.org/10.1080/09537104.2019.1704715.
  15. Chen X, Wang D, Dong R, et al. Effects of hypersplenism on the outcome of hepatectomy in hepatocellular carcinoma with hepatitis B virus related portal hypertension. Frontiers in surgery. 2023; 10: 1118693. https://doi.org/10.3389/ fsurg.2023.1118693.
  16. Bai D-S, Zhou B-H, Qian J-J, et al. Effects of laparoscopic splenectomy and azygoportal disconnection on liver synthesis function and cirrhosis: a 2-year prospective study. Surgical Endoscopy. 2019; 34(11): 5074–5082. https://doi.org/10.1007/ s00464-019-07307-7.
  17. Lv Y, Wu H, Lau WY, et al. Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertension. Scientific Reports. 2021; 11: 21246 https://doi.org/10.1038/ s41598-021-00692-x.
  18. Sharon CE, Straker RJ, Perry N, et al. Postsplenectomy morbidity and mortality in patients with immune thrombocytopenic purpura: A national cohort study. Journal of surgical oncology. 2022; 126(4): 718–727. https://doi.org/10.1002/jso.26986.
  19. Tutchenko MI, Rudyk DV, Klyuzko ІV, et al. Treatment of portal hypertension complicated by variceal bleeding. Emergency Medicine. 2024; 20(3): 180–185. https://doi.org/10.22141/2224-0586.20.3.2024.1690.
  20. Ding H, Zhang Y, Zhao L, et al. What intervention regimen is most effective prevention for Portal venous system thrombosis after splenectomy in cirrhotics patients with Portal hypertension? Systematic review and network metaanalysis. Pharmacological Research. 2020; 157: 104825. https://doi.org/10.1016/j.phrs.2020.104825.
View article PDF